Clinical Trial Update: Trial of Progesterone in Twins and Triplets to Prevent Preterm Birth (STTARS) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating progesterone to prevent preterm birth in twins and triplets has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: The George Washington University Biostatistics Center | Conditions: Preterm Birth, Pregnancy | Phase 3 | Status: COMPLETED